Adnan Kastrati

Showing 1-20 of 40 articles

Coronary interventions

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation

Goedel A, Fiedler K, Mehilli J, Bernlochner I, von Olshausen G, Mayer K, Schüpke S, Hoppmann P, Sibbing D, Maeng M, Massberg S, Schunkert H, Laugwitz K, Kastrati A, Sarafoff N

October 18, 2019 | 10.4244/EIJ-D-18-00995

Coronary interventions

Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

October 1, 2019 | 10.4244/EIJ-D-19-00488

Coronary interventions

Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss H, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne R, Laugwitz K, Schunkert H, Massberg S, Kastrati A, Mehilli J

September 20, 2019 | 10.4244/EIJ-D-18-00603

Interventions for valvular disease

Hemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves

Rheude T, Pellegrini C, Cassese S, Wiebe J, Wagner S, Trenkwalder T, Alvarez H, Mayr P, Hengstenberg C, Schunkert H, Kastrati A, Husser O, Joner M

September 10, 2019 | 10.4244/EIJ-D-19-00710

Peripheral interventions

Incidence and Predictors of Stent Thrombosis after Endovascular Revascularisation of the Superficial Femoral Artery

Bradaric C, Koppara T, Müller A, Haller B, Ott I, Cassese S, Fusaro M, Kastrati A, Laugwitz K, Ibrahim T

July 30, 2019 | 10.4244/EIJ-D-19-00187

Omission of aspirin after ACS or stenting in patients with oral anticoagulation – why have the goalposts moved?

Byrne R, Colleran R, Kastrati A

April 5, 2019 | 10.4244/EIJV14I18A312

Coronary interventions

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iniguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P

February 5, 2019 | 10.4244/EIJ-D-18-01080

No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms

Ndrepepa G, Colleran R, Kastrati A

June 20, 2018 | 10.4244/EIJV14I2A21

Coronary interventions

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Lahmann AL, Mankerious N, Xhepa E, Laugwitz K, Schunkert H, Fusaro M, Kastrati A, Joner M

June 20, 2018 | 10.4244/EIJ-D-18-00024

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

Cassese S, Byrne R, Jüni P, Wykrzykowska J, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques J, Serruys P, Windecker S, Kastrati A

January 19, 2018 | 10.4244/EIJ-D-17-00492

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary

Byrne R, Stefanini GG, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys P, Windecker S

January 19, 2018 | 10.4244/EIJ20170912-01

Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI)

Ott I, Shivaraju A, Schafer N, Frangieh A, Michel J, Husser O, Hengstenberg C, Mayr P, Colleran R, Pellegrini C, Cassese S, Fusaro M, Schunkert H, Kastrati A, Kasel A

October 20, 2017 | 10.4244/EIJ-D-16-01036

Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis

Colleran R, Harada Y, Kufner S, Giacoppo D, Joner M, Cassese S, Ibrahim T, Laugwitz K, Kastrati A, Byrne R

October 20, 2017 | 10.4244/EIJ-D-16-00939

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Xhepa E, De Waha A, Rheude T, Colleran R, Giacoppo D, Harada Y, Laugwitz K, Schunkert H, Fusaro M, Kastrati A

October 20, 2017 | 10.4244/EIJ-D-16-00871

Coronary interventions

State of the art: coronary artery stents – past, present and future

Stefanini GG, Byrne R, Windecker S, Kastrati A

August 25, 2017 | 10.4244/EIJ-D-17-00557

Peripheral interventions

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis

Cassese S, Ndrepepa G, Kufner S, Byrne R, Giacoppo D, Ott I, Laugwitz K, Schunkert H, Kastrati A, Fusaro M

July 20, 2017 | 10.4244/EIJ-D-16-00735

Interventions for hypertension

Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease

Bradaric C, Eser K, Preuss S, Dommasch M, Wustrow I, Langwieser N, Haller B, Ott I, Fusaro M, Heemann U, Laugwitz K, Kastrati A, Ibrahim T

June 2, 2017 | 10.4244/EIJ-D-16-00697

Coronary interventions

Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique

Harada Y, Colleran R, Pinieck S, Giacoppo D, Michel J, Kufner S, Cassese S, Joner M, Ibrahim T, Laugwitz K, Kastrati A, Byrne R

April 20, 2017 | 10.4244/EIJ-D-16-00226

Coronary interventions

Don’t think twice: BMS is never nice

Colleran R, Kastrati A

January 20, 2017 | 10.4244/EIJV12I13A258

Coronary interventions

Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI

Ndrepepa G, Kastrati A

June 20, 2016 | 10.4244/EIJV12I3A52

Latest news

New issue

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Insight

The SYNTAX score on its way out or … towards artificial intelligence

November 1, 2019

Free Access

New this week: Deep Learning, near-infrared spectroscopy and much more

November 12, 2019

Trials Book

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Free Access

Last week's JAA's: 1-year EffPac trial results & Sheathless vs conventional access

November 5, 2019

Adnan Kastrati

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke